Martin Shkreli has been put in solitary confinement amid allegations he was running his drug company from prison using a contraband smartphone, a person familiar with the matter told The Associated Press.
Martin Shkreli , former chief executive of Turing Pharmaceuticals, and his attorney Benjamin Brafman , talk to reporters at the United States federal courthouse in Brooklyn, New York on August 4, 2017. Shkreli, who was accused of defrauding his hedge fund investors and a pharmaceutical company, was convicted on three of eight counts of fraud.Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
The U.S. Bureau of Prisons told the AP on March 8 that it was investigating whether Shkreli, known as the"Pharma Bro," violated prison rules forbidding inmates from conducting business and possessing cellphones. "The matter you reference is under investigation," the agency said in a statement."When there are allegations of misconduct, they are thoroughly investigated and appropriate action is taken if allegations are sustained."
The Wall Street Journal reported last month that Shkreli has used a cellphone to call the shots at his drug company, Phoenixus AG, posting regularly to social media and even firing the company's chief executive.If it's prosecuted in court, a conviction could tack on up to an extra year of prison time.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Feds investigate Martin 'Pharma Bro' Shkreli for allegedly running a drug business from prisonFeds investigate 'Pharma Bro' Martin Shkreli for allegedly running a drug business from prison.
Weiterlesen »
Sources: Martin Shkreli Thrown In Solitary Confinement After Claims He Ran Company From PrisonMartin Shkreli is in solitary confinement and under investigation by prison authorities following a report that he continued to run his pharma business from behind bars using a contraband phone by iblametom
Weiterlesen »
Amid the opioid scandal, what next for Purdue Pharma and the Sackler family?Our weekly podcast on the markets, the economy and the world of business
Weiterlesen »
New York AG sues Purdue Pharma, J&J, McKesson in case against opioid manufacturers and distributorsThe New York Attorney General is filing new allegations against Purdue Pharma and the Sackler Family, according to The Wall Street Journal.
Weiterlesen »
AstraZeneca inks $6.9 billion cancer drug pact with Japanese pharma firm Daiichi SankyoAstraZeneca and Japan's Daiichi Sankyo signed a potential multibillion-dollar deal to develop and sell Daiichi's cancer drug trastuzumab deruxtecan.
Weiterlesen »
Purdue's Sackler family fights 'inflammatory' Massachusetts opioid caseMembers of the Sackler family behind OxyContin maker Purdue Pharma LP have asked...
Weiterlesen »
N.Y. accuses opioid maker Purdue of illegal fund transfers to SacklersPurdue Pharma LP fraudulently transferred funds to members of the wealthy Sackle...
Weiterlesen »
Purdue Pharma’s Sackler family wants opioid lawsuit thrown outThe Sackler family, which controls OxyContin maker Purdue Pharma, says a Massachusetts lawsuit that alleges Purdue fueled the opioid epidemic relies on false assertions.
Weiterlesen »